A Randomized Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir for 8 Weeks and Sofosbuvir/Velpatasvir for 12 Weeks for Patients with Genotype 3 HCV Infection and Cirrhosis: The POLARIS-3 StudyGraham R. Foster,Alex J. Thompson,Peter J. Ruane,Sergio M. Borgia,Gregory Dore,Kimberly Workowski,Robert H. Hyland,Jing Wang,Evguenia S. Svarovskaia,Luisa M. Stamm,Diana M. Brainard,Mani Subramanian,John G. McHutchison,Thomas Berg,Kosh Agarwal,Brian Conway,Jordan J. Feld,Bernard E. Willems,Stuart K. RobertsHEPATOLOGY（2016）引用 0|浏览22暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
